Antileishmanial Activity of Lignans, Neolignans …
159
32. Bates PA (2008) Leishmania sandfly interaction: progress and challenges. Curr Opin
Microbiol 11:340
33. Sacks DL, Perkins PV (1985) Development of infective stage Leishmania promastigotes
within phlebotomine sand flies. Am J Trop Med Hyg 34:456
34. De Muylder G, Ang KKH, Chen S, Arkin MR, Engel JC McKerrow JH (2011) A screen against
leishmania intracellular amastigotes: comparison to a promastigote screen and identification
of a host cell-specific hit. PLoS Negl Trop Dis 5:e1253
35. Cunningham ML, Titus RG, Turco SJ, Beverley SM (2001) Regulation of differentiation to the
infective stage of the protozoan parasite Leishmania major by tetrahydrobiopterin. Science
292:285
36. Sádlová J, Price HP, Smith BA, Votýpka J, Volf P, Smith DF (2010) The stage-regulated
HASPB and SHERP proteins are essential for differentiation of the protozoan parasite
Leishmania major in its sand fly vector, Phlebotomus papatasi. Cell Microbiol 12:1765
37. Peters NC, Egen JG, Secundino N, Debrand A, Kimblin N, Kamhawi S, Lawyer P, Fay MP,
Germain RN, Sacks D (2008) In vivo imaging reveals an essential role for neutophils in
leishmaniasis transmitted by sandflies. Science 321:970
38. Atayde VD, Aslan H, Townsend S, Hassani K, Kamhawi S, Olivier M (2015) Exosome
secretion by the parasitic protozoan Leishmania within the sandfly midgut. Cell Rep 13:957
39. Theodos CM, Titus RG (1993) Salivary gland material from the sandfly Lutzomyia longipalpis
has an inhibitory effect on macrophage function in vitro. Parasite Immunol 15:481
40. Bhunia GS, Kesari S, Jeyaram A, Kumar V, Das P (2010) Influence of topography on the
endemicity of kala-azar: a study based on remote sensing and geographical information
system. Geospat Health 4:155
41. Ready P (2014) Epidemiology of visceral leishmaniasis. Clin Epidemiol 6:147
42. Murray HW, Berman JD, Davies CR, Saravia NG (2005) Advances in leishmaniasis. Lancet
366:1561
43. Tiuman TS, Santos AO, Ueda-Nakamura T, Filho BPD, Nakamura CV (2011) Recent advances
in leishmaniasis treatment. Int J Infect Dis 15:e525
44. Zacarias DA, Rolão N, de Pinho FA, Sene I, Silva JC, Pereira TC, Costa DL, Costa CHN (2017)
Causes and consequences of higher Leishmania infantum burden in patients with kala-azar:
a study of 625 patients. Trop Med Int Heal 22:679
45. Lima Verde FA, Lima Verde FAA, Saboia Neto A, Almeida PC, Lima Verde EM (2011)
Hormonal disturbances in visceral leishmaniasis (kala-azar). Am J Trop Med Hyg 84:668
46. Pearson RD, De Queiroz Sousa A (1996) Clinical spectrum of leishmaniasis. Clin Infect Dis
22:1
47. Elmahallawy EK, Sampedro Martínez A, Rodriguez-Granger J, Hoyos-Mallecot Y, Agil A,
Navvaro Mari JM, Gutierrez Fernandéz J (2014) Diagnosis of leishmaniasis. J Infect Dev
Ctries 8:961
48. Scott P, Novais FO (2016) Cutaneous leishmaniasis: immune responses in protection and
pathogenesis. Nat Rev Immunol 16:581
49. Mokni M (2019) Cutaneous leishmaniasis. Ann Dermatol Venereol 146:232
50. Dowlati Y (1996) Cutaneous leishmaniasis: clinical aspect. Clin Dermatol 14:425
51. Kumar R, Engwerda C (2014) Vaccines to prevent leishmaniasis. Clin Transl Immunol 3:e13
52. Croft SL, Sundar S, Fairlamb AH (2006) Drug resistance in leishmaniasis. Clin Microbiol
Rev 19:111
53. Jaafari MR, Hatamipour M, Alavizadeh SH, Abbasi A, Saberi Z, Rafati S, Taslimi Y, Mohammadi AM, Khamesipour A (2019) Development of a topical liposomal formulation of amphotericin B for the treatment of cutaneous leishmaniasis. Int J Parasitol Drugs Drug Resist
11:156
54. Patil RS, Patil MS, Kshirsagar SS, Chaudhari PS, Bayas JP, Oswald RJ (2012) Synthetic and
natural products against leishmaniasis: a review. World J Public Health Sci 1:7
55. Jha TK (1983) Evaluation of diamidine compound (pentamidine isethionate) in the treatment
of resistant cases of kala-azar occurring in North Bihar, India. Trans R Soc Trop Med Hyg
77:167
159
32. Bates PA (2008) Leishmania sandfly interaction: progress and challenges. Curr Opin
Microbiol 11:340
33. Sacks DL, Perkins PV (1985) Development of infective stage Leishmania promastigotes
within phlebotomine sand flies. Am J Trop Med Hyg 34:456
34. De Muylder G, Ang KKH, Chen S, Arkin MR, Engel JC McKerrow JH (2011) A screen against
leishmania intracellular amastigotes: comparison to a promastigote screen and identification
of a host cell-specific hit. PLoS Negl Trop Dis 5:e1253
35. Cunningham ML, Titus RG, Turco SJ, Beverley SM (2001) Regulation of differentiation to the
infective stage of the protozoan parasite Leishmania major by tetrahydrobiopterin. Science
292:285
36. Sádlová J, Price HP, Smith BA, Votýpka J, Volf P, Smith DF (2010) The stage-regulated
HASPB and SHERP proteins are essential for differentiation of the protozoan parasite
Leishmania major in its sand fly vector, Phlebotomus papatasi. Cell Microbiol 12:1765
37. Peters NC, Egen JG, Secundino N, Debrand A, Kimblin N, Kamhawi S, Lawyer P, Fay MP,
Germain RN, Sacks D (2008) In vivo imaging reveals an essential role for neutophils in
leishmaniasis transmitted by sandflies. Science 321:970
38. Atayde VD, Aslan H, Townsend S, Hassani K, Kamhawi S, Olivier M (2015) Exosome
secretion by the parasitic protozoan Leishmania within the sandfly midgut. Cell Rep 13:957
39. Theodos CM, Titus RG (1993) Salivary gland material from the sandfly Lutzomyia longipalpis
has an inhibitory effect on macrophage function in vitro. Parasite Immunol 15:481
40. Bhunia GS, Kesari S, Jeyaram A, Kumar V, Das P (2010) Influence of topography on the
endemicity of kala-azar: a study based on remote sensing and geographical information
system. Geospat Health 4:155
41. Ready P (2014) Epidemiology of visceral leishmaniasis. Clin Epidemiol 6:147
42. Murray HW, Berman JD, Davies CR, Saravia NG (2005) Advances in leishmaniasis. Lancet
366:1561
43. Tiuman TS, Santos AO, Ueda-Nakamura T, Filho BPD, Nakamura CV (2011) Recent advances
in leishmaniasis treatment. Int J Infect Dis 15:e525
44. Zacarias DA, Rolão N, de Pinho FA, Sene I, Silva JC, Pereira TC, Costa DL, Costa CHN (2017)
Causes and consequences of higher Leishmania infantum burden in patients with kala-azar:
a study of 625 patients. Trop Med Int Heal 22:679
45. Lima Verde FA, Lima Verde FAA, Saboia Neto A, Almeida PC, Lima Verde EM (2011)
Hormonal disturbances in visceral leishmaniasis (kala-azar). Am J Trop Med Hyg 84:668
46. Pearson RD, De Queiroz Sousa A (1996) Clinical spectrum of leishmaniasis. Clin Infect Dis
22:1
47. Elmahallawy EK, Sampedro Martínez A, Rodriguez-Granger J, Hoyos-Mallecot Y, Agil A,
Navvaro Mari JM, Gutierrez Fernandéz J (2014) Diagnosis of leishmaniasis. J Infect Dev
Ctries 8:961
48. Scott P, Novais FO (2016) Cutaneous leishmaniasis: immune responses in protection and
pathogenesis. Nat Rev Immunol 16:581
49. Mokni M (2019) Cutaneous leishmaniasis. Ann Dermatol Venereol 146:232
50. Dowlati Y (1996) Cutaneous leishmaniasis: clinical aspect. Clin Dermatol 14:425
51. Kumar R, Engwerda C (2014) Vaccines to prevent leishmaniasis. Clin Transl Immunol 3:e13
52. Croft SL, Sundar S, Fairlamb AH (2006) Drug resistance in leishmaniasis. Clin Microbiol
Rev 19:111
53. Jaafari MR, Hatamipour M, Alavizadeh SH, Abbasi A, Saberi Z, Rafati S, Taslimi Y, Mohammadi AM, Khamesipour A (2019) Development of a topical liposomal formulation of amphotericin B for the treatment of cutaneous leishmaniasis. Int J Parasitol Drugs Drug Resist
11:156
54. Patil RS, Patil MS, Kshirsagar SS, Chaudhari PS, Bayas JP, Oswald RJ (2012) Synthetic and
natural products against leishmaniasis: a review. World J Public Health Sci 1:7
55. Jha TK (1983) Evaluation of diamidine compound (pentamidine isethionate) in the treatment
of resistant cases of kala-azar occurring in North Bihar, India. Trans R Soc Trop Med Hyg
77:167